Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies

Qiongyu Hao1, Yanyuan Wu1,2, Jaydutt V Vadgama1,2

  • 1Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.

Biomolecules
|September 23, 2022
PubMed

Insights

Natural compounds from plants, known as phytochemicals, show promise in fighting prostate cancer. These natural agents can inhibit cancer growth and may enhance conventional treatments with fewer side effects.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Prostate cancer is a leading cause of male mortality worldwide.
  • Conventional therapies face challenges due to resistance, toxicity, and side effects.
  • Phytochemicals from plants exhibit cytotoxic properties against tumors.

Purpose of the Study:

  • To systematically review literature on naturally occurring compounds for prostate cancer treatment.
  • To elucidate the mechanisms of action of these phytochemicals.
  • To explore their role in modulating key cancer pathways.

Main Methods:

  • Systematic literature review of naturally occurring compounds.
  • Analysis of in vitro and pre-clinical studies.
  • Focus on compounds isolated from vegetables, fruits, teas, and herbs.

Main Results:

  • Phytochemicals modulate crucial cellular signaling pathways in prostate cancer.
  • Natural compounds induce cell cycle arrest, apoptosis, and inhibit angiogenesis.
  • Combinatorial use with conventional drugs shows potential for enhanced efficacy and reduced toxicity.

Conclusions:

  • Phytochemicals offer a promising avenue for prostate cancer treatment, potentially with significant health benefits.
  • Understanding their structure-based anti-cancer mechanisms can aid drug development and combination therapies.
  • Natural compounds can interfere with cell proliferation, cell cycle control, apoptosis, autophagy, angiogenesis, invasion, and metastasis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K